Cannabics Pharmaceuticals is dedicated to the development of Personalized Anti-Cancer treatments.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Bethesda
State: Maryland
Zip:
Country: United States
Cannabics Pharmaceuticals (CNBX), a U.S based company, is dedicated to the development of Palliative and personalized Anti-Cancer treatments. The Company&s;s scientific focus is on harnessing the therapeutic properties of natural Cannabinoids. Cannabics&s; vision is to create tailored therapies for cancer patients, utilizing advanced screening systems and bioinformatic tools. The Company&s;s R&a;D is based in Israel, where it is licensed by the Ministry of Health and involves both scientific and academic research as well as current medical clinical studies
Contact Phone:
Contact Email:
Listed Exchange:
OTCQB
IPO Date:
6/20/2014
Ticker Symbol:
CNBX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | Post-IPO Equity | $3M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|